Richard Nolan Townsend

Insider Reports History

Entity
Individual
Location
C/O Lexeo Therapeutics, Inc., 345 Park Avenue South, 6 Th Floor, New York, NY
Signature
/s/ Youjin Choi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Nolan Townsend:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lexeo Therapeutics, Inc. Chief Executive Officer, Director Common Stock 121K $944K $7.82 Nov 11, 2024 Direct
Lexeo Therapeutics, Inc. Chief Executive Officer, Director Stock Option (right to buy) 121K Nov 11, 2024 Direct

Insider Reports Filed by Richard Nolan Townsend

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LXEO Lexeo Therapeutics, Inc. Nov 11, 2024 3 -$13.7K 4 Nov 13, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Oct 10, 2024 3 -$28.8K 4 Oct 15, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Sep 10, 2024 3 -$41.6K 4 Sep 11, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Aug 12, 2024 3 -$46K 4 Aug 13, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Jul 10, 2024 6 -$912K 4 Jul 12, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Jun 10, 2024 4 -$76.6K 4 Jun 12, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. May 13, 2024 3 -$66.1K 4 May 14, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Jan 5, 2024 2 $0 4 Jan 9, 2024 Chief Executive Officer, Director
LXEO Lexeo Therapeutics, Inc. Nov 2, 2023 0 $0 3 Nov 2, 2023 Chief Executive Officer, Director